Other
Common stock, shares issued (in shares)
Roivant Sciences Common stock, shares issued (in shares) increased by 2.9% to $709.69M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $719.63M to $709.69M. Over 4 years (FY 2020 to FY 2024), Common stock, shares issued (in shares) shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ4 2025
How to read this metric
Increases indicate equity financing or stock-based compensation, while decreases result from share buybacks.
Detailed definition
This represents the total number of shares that the company has distributed to shareholders. It includes both shares cur...
Peer comparison
Used to calculate earnings per share and evaluate dilution trends compared to industry peers.
Metric ID:
other_common_stock_shares_issuedHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $222.67M | $684.79M | $692.01M | $694.98M | $701.17M | $704.39M | $726.80M | $760.14M | $767.14M | $800.79M | $804.89M | $806.68M | $739.05M | $733.33M | $719.63M | $695.94M | $682.23M | $689.70M | $709.69M |
| QoQ Change | — | +207.5% | +1.1% | +0.4% | +0.9% | +0.5% | +3.2% | +4.6% | +0.9% | +4.4% | +0.5% | +0.2% | -8.4% | -0.8% | -1.9% | -3.3% | -2.0% | +1.1% | +2.9% |
| YoY Change | — | — | — | — | +214.9% | +2.9% | +5.0% | +9.4% | +9.4% | +13.7% | +10.7% | +6.1% | -3.7% | -8.4% | -10.6% | -13.7% | -7.7% | -5.9% | -1.4% |
Range$222.67M – $806.68M
CAGR+29.4%
Avg YoY Growth+14.7%
Median YoY Growth+2.9%
Current Streak2 quarters growth
Common stock, shares issued (in shares) at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's common stock, shares issued (in shares)?
- Roivant Sciences (ROIV) reported common stock, shares issued (in shares) of $709.69M in Q4 2025.
- How has Roivant Sciences's common stock, shares issued (in shares) changed year-over-year?
- Roivant Sciences's common stock, shares issued (in shares) decreased by 1.4% year-over-year, from $719.63M to $709.69M.
- What is the long-term trend for Roivant Sciences's common stock, shares issued (in shares)?
- Over 4 years (2020 to 2024), Roivant Sciences's common stock, shares issued (in shares) has grown at a 1.7% compound annual growth rate (CAGR), from $651.58M to $695.94M.
- What does common stock, shares issued (in shares) mean?
- The total number of shares the company has created and distributed to investors.